IP Library Granted Patent US 10,954,558
Granted Patent B2
US 10,954,558 · App. 16/168,395 · Granted Mar 23, 2021

Methods for processing nucleic acid samples

Inventors: Arkadiusz Bibillo (Cupertino, CA); Pranav Patel (Freemont, CA)
Assignee: Bio-Rad Laboratories, Inc.
C12Q1/686C12N9/1276C12N15/1096C12P19/34C12Q1/68C12Q1/6806C12Q1/6846C12Q2600/112C12Q2600/118C12Q2600/158C12Q2600/16C12Q2600/178C12Y207/07049
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,954,558
App. No.
16/168,395
Granted
Mar 23, 2021
Kind
B2
Abstract

The present disclosure provides methods and systems for amplifying and analyzing nucleic acid samples. The present disclosure provides methods for preparing cDNA and/or DNA molecules and cDNA and/or DNA libraries using modified reverse transcriptases.

Claims (21)

1. A kit, comprising: an R2 reverse transcription enzyme comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 49, SEQ ID NO: 50, SEQ ID NO: 51, SEQ ID NO: 53, SEQ ID NO: 54, SEQ ID NO: 55, SEQ ID NO: 56, SEQ ID NO: 57, SEQ ID NO: 58, SEQ ID NO: 59, SEQ ID NO: 60, SEQ ID NO: 61, SEQ ID NO: 62, SEQ ID NO: 63, SEQ ID NO: 64, SEQ ID NO: 65, SEQ ID NO: 66, and SEQ ID NO: 67.

2. The kit of claim 1 , wherein said R2 reverse transcription enzyme has a misincorporation error rate of at most about 1 base out of 100 bases.

3. The kit of claim 1 , wherein said R2 reverse transcription enzyme is configured to generate a plurality of complementary deoxyribonucleic acid molecules from one or more template ribonucleic acid molecules with a specific activity of from about 20,000 units/mg to about 140,000 units/mg.

4. The kit of claim 1 , wherein said R2 reverse transcription enzyme is capable of template jumping independent of sequence identity between said template ribonucleic acid molecule and an acceptor nucleic acid molecule.

5. The kit of claim 1 , wherein said R2 reverse transcription enzyme comprises SEQ ID NO:50.

6. The kit of claim 1 , wherein said R2 reverse transcription enzyme comprises SEQ ID NO:51.

7. The kit of claim 1 , wherein said R2 reverse transcription enzyme comprises SEQ ID NO:53.

8. The kit of claim 1 , wherein said R2 reverse transcription enzyme comprises SEQ ID NO:54.

9. The kit of claim 1 , wherein said R2 reverse transcription enzyme comprises SEQ ID NO:55.

10. The kit of claim 1 , wherein said R2 reverse transcription enzyme comprises SEQ ID NO:56.

11. The kit of claim 1 , wherein said R2 reverse transcription enzyme comprises SEQ ID NO:57.

12. The kit of claim 1 , wherein said R2 reverse transcription enzyme comprises SEQ ID NO:58.

13. The kit of claim 1 , wherein said R2 reverse transcription enzyme comprises SEQ ID NO:59.

14. The kit of claim 1 , wherein said R2 reverse transcription enzyme comprises SEQ ID NO:60.

15. The kit of claim 1 , wherein said R2 reverse transcription enzyme comprises SEQ ID NO:61.

16. The kit of claim 1 , wherein said R2 reverse transcription enzyme comprises SEQ ID NO:62.

17. The kit of claim 1 , wherein said R2 reverse transcription enzyme comprises SEQ ID NO:63.

18. The kit of claim 1 , wherein said R2 reverse transcription enzyme comprises SEQ ID NO:64.

19. The kit of claim 1 , wherein said R2 reverse transcription enzyme comprises SEQ ID NO:65.

20. The kit of claim 1 , wherein said R2 reverse transcription enzyme comprises SEQ ID NO:66.

21. The kit of claim 1 , wherein said R2 reverse transcription enzyme comprises SEQ ID NO:67.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2019
From: 2D GENOMICS INC.
To: BIO-RAD LABORATORIES, INC.
Reel/Frame 049078/0089 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2018
From: BIBILLO, ARKADIUSZ; PATEL, PRANAV
To: 2D GENOMICS INC.
Reel/Frame 047325/0916 →
Continuity (4)
Continuation PCTUS2017061197 · Nov 10, 2017
Provisional Application 62477211 · Mar 27, 2017
Provisional Application 62421028 · Nov 11, 2016
Related Publication 20190040454A1 · Feb 7, 2019